Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000950170-23-031789

Options or other derivatives

  • Director acquired 24,606 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
JOYCE MARTIN JOSEPH Director 2023-06-30 Grant or award · Stock Option (Right to Buy) +21,222 21,222 D
JOYCE MARTIN JOSEPH Director 2023-06-30 Grant or award · Stock Option (Right to Buy) +640 640 D
JOYCE MARTIN JOSEPH Director 2023-06-30 Grant or award · Stock Option (Right to Buy) +2,744 2,744 D
Loading xslF345X04/ownership.xml…